Concern over Framingham funding cuts

The iconic Framingham Heart Study, which has been the mainstay of cardiovascular risk prediction tools, faces crippling cutbacks that threaten its viability, cardiologists warn.

The US Congress is to impose an arbitrary 44% funding cut on the Framingham study as part of a wide-ranging sequestration program that will cut $US2.5 trillion in government spending across the board.

With its $US9 million budget slashed by $US4 million, the Framingham Heart Study, which has been running for six decades, will lose about 20 researchers and clinicians and scale back or abandon many of its cardiovascular risk